Enovis (ENOV) Current Deferred Tax Assets (2010 - 2011)
Enovis (ENOV) reported Current Deferred Tax Assets of $9.4 million for Q4 2011, up 54.01% year-over-year from $6.1 million in Q4 2010, and up 47.82% on a QoQ basis from $6.4 million in Q3 2011.
Enovis (ENOV) has 2 years of Current Deferred Tax Assets data on file, last reported at $9.4 million in Q4 2011.
- Quarterly Current Deferred Tax Assets rose 54.01% year-over-year to $9.4 million in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $9.4 million (up 54.01% YoY) and the FY2011 annual result came in at $9.4 million, up 54.01% from the prior year.
- Current Deferred Tax Assets grew to $9.4 million in Q4 2011 per ENOV's latest filing, from $6.4 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $9.4 million in Q4 2011 and bottomed at $6.1 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 9.41 Mn |
| Dec 31, 2011 | 9.41 Mn |
| Sep 30, 2011 | 6.36 Mn |
| Sep 30, 2011 | 6.36 Mn |
| Jul 1, 2011 | 6.57 Mn |
| Jul 1, 2011 | 6.57 Mn |
| Dec 31, 2010 | 6.11 Mn |
| Dec 31, 2010 | 6.11 Mn |